Trial Profile
Risk evaluation of development of hepatocellular carcinoma in hepatitis B (HBV) patients treated with entecavir and lamivudine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 20 Dec 2015 New trial record